Use with the Hypoglycaemia Care Plan for babies on Labour and Postnatal Wards.
|
|
- Diane McCoy
- 6 years ago
- Views:
Transcription
1 Preventin and Management f Hypglycaemia Use with the Hypglycaemia Care Plan fr babies n Labur and Pstnatal Wards. General Principles 1) Anticipate hypglycaemia in high risk infants 1. cnsider pre-delivery breast milk harvesting 2. ensure hypglycaemia plan knwn prir t delivery 2) Initiate feeds early and three hurly feeds thereafter fr high risk babies 3) Dn t d bld sugar befre baby is 2 hurs ld unless there are clinical signs 4) Give dextrse gel t infants in crrect amunts, prmptly, accrding t bld sugar 5) Keep babies warm at all times 6) Avid separatin f mthers and infants. 7) Supprt establishing breast feeding 1. Use f dextrse gel as first line treatment fr hypglycaemia 2. Encurage expressin f breast milk fr use as feed supplement, nly use frmula supplements at 60mls/kg/d if n EBM available 3. Passing f nasgastric tube and admissin t SCU (with mther) if mre frequent feeds/larger feed vlumes required 8) The rle f the nenatal SHO/Registrar is t take a histry, lk fr risk factrs, examine the baby fr signs/symptms f hypglycaemia, review the charts, supprt the parent(s) and midwife, and ensure baby is managed accrding t the guideline. 9) If enteral feeding insufficient t maintain nrmal bld sugar levels, t cmmence IV dextrse 1. Avid IV blus f dextrse if pssible 2. Start IV glucse lad at 4--6mg/kg/min and increase in steps f 2mg/kg/min 3. Use f 5 and 50 glucse regime fr independent management f glucse lad and flw rate 10) Treat severe hypglycaemia 1.0mml/L urgently with IV glucse ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
2 Bld glucse levels in the nenate As part f the nrmal pstnatal adaptatin, newbrn infants bld glucse levels fall immediately fllwing delivery, reaching the lwest levels within 1-2 hurs after birth. After that, in healthy, nrmally grwn term babies the levels then spntaneusly recver as feeds are established. The nenatal brain uses lactate as an alternative metablic fuel whilst feeding is being established in the first hurs. Hwever recent evidence indicates that there is als a hypkettic state and s babies remain vulnerable until their bld sugar level nrmalises. There are sme grups f newbrns wh are at greater risk f symptmatic hypglycaemia and risk f neurnal damage. Preterm infants and Small fr Gestatinal Age babies (GROW prtcl) may have reduced glycgen stres, impaired glucnegenesis due t liver immaturity and additinal suppressin f ketnes prductin (as an alternative substrate). Large babies (>4.5kg) r babies with diabetic mthers are at risk f hyperinsulinism causing prfund hypglycaemia. Other at-risk grups are defined belw. Definitin f hypglycaemia We use different levels f bld sugar level (BSL) t define the actins necessary 1. BSL f 2.6mml/L r mre is nrmal 2. BSL between 1.8 and 2.5mml/L is usually transitinal 3. BSL between 1.5 and 1.8mml/L may be physilgical but may be pathlgical 4. BSL f 1.5mml/L r less, if prlnged, may put the baby at risk f neurnal damage 5. BSL f 1.0mml/L r less is severe hypglycaemia and requires urgent IV treatment Symptms and signs f hypglycaemia Neurgenic (sympathetic nervus activity): jitteriness, tachycardia, pallr, hypthermia Neurglycpenic (impaired brain functin): flppiness, sleepiness (mre than 8 hurs between feeds), irritability, pr feeding, cyansis, tachypnea, apneic episdes, weak r high-pitched cry, seizures. Measurement f bld sugar levels (BSL) D nt check a BSL in a baby less than 2 hurs ld lw BSL are nrmal befre then unless there are clear clinical signs f hypglycaemia. The quickest / mst cnvenient way t measure BSL is with a handheld bld glucse meter. These cnsistently underestimate the actual sugar level cmpared t capillary bld gas glucse (CBGS). Thus a lw/brderline reading n prtable glucse meter shuld be checked with a CBGS, althugh treatment (e.g. with dextrse gel) shuld nt be delayed Jitteriness Jitteriness is a prly defined symptm and is nt a definitive sign f hypglycaemia (UNICEF). Many babies will appear jittery n handling, therefre a definitin such as the fllwing is suggested: Excessive repetitive mvements f ne r mre limbs, which are unprvked and usually relatively fast. It is imprtant t be sure that this mvement is nt simply a respnse t stimuli. ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
3 Measures fr preventin and management f hypglycaemia Babies are at LOW r HIGH risk fr hypglycaemia which is ften preventable General measures t PREVENT hypglycaemia apply t all babies: Keep babies warm and dry Offer feeds early (high risk babies within 30 minutes f birth, lw risk within 3 hurs) The risk f hypglycaemia shuld be anticipated and assessed n Delivery Suite by the midwife caring fr the mther and newbrn infant. LOW RISK INFANTS Nrmally grwn term infants wh are well, warm and feeding prperly are at lw risk f hypglycaemia and d nt require rutine BSL testing. Infrequent feeding in a well infant is nt an indicatin fr BSL testing it is usual fr a baby t feed as little as 4 times in the first 24 hurs f life - but a baby shuld nt g fr lnger than 8 hurs between feeds. If there are clinical cncerns if baby becmes systemically unwell r there are signs f hypglycaemia, manage baby accrding t the Clinical Cncern Pathway (belw) HIGH RISK INFANTS High risk babies shuld be identified by their midwife n Delivery Suite and the Hypglycaemia Care Plan shuld be cmmenced and placed in the ntes. Babies will fllw the Infant at Risk Pathway. High risk criteria include any ne r mre f: Prematurity (<37 weeks gestatin including all babies up t and including 36+6 weeks) Small fr Gestatinal Age (GROW prtcl less than 10 th centile n EFW/BW)* Large fr dates ( 4.5kg birth weight) Diabetic mther (all types) Infants f wmen with diabetes are als at higher risk f persistent respiratry distress, cngenital heart disease, plycythaemia, and severe jaundice. If there are any clinical cncerns in these infants, the Nenatal SHO shuld be called t review the baby. Other factrs may increase the risk f nenatal hypglycaemia: Maternal drug therapy (beta blckers, sdium valprate) Infectin Plycythaemia Hypxic-ischaemic encephalpathy Respiratry distress Inbrn errrs f metablism Syndrmes such as Beckwith- Wiedemann Rebund hypglycaemia fllwing IV dextrse blus * The GROW prtcl is used antenatally t identify babies wh are SGA based n parental characteristics such as ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
4 height and ethnicity. It is administered by the Perinatal Institute. The use f GROW natinally and by regin (e.g. Suth East Cast can be fund here). Mre infrmatin abut GROW can be accessed here. ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
5 Hypglycaemia Care Pathway: Preventing and Managing Hypglycaemia in Newbrns Mst babies at risk f / with hypglycaemia will be managed by midwives n Delivery Suite/ Pstnatal Ward withut the need fr escalatin f medical interventin beynd dextrse gel administratin. This apprach supprts breastfeeding and bnding, reduces the number f heel-pricks fr the baby and shrtens the length f stay. BSL f 2.6mml/L (r mre) is the THERAPEUTIC OBJECTIVE BSL f 1.8mml/L is the OPERATIONAL THRESHOLD (nenatal medical team infrmed) There are 3 escalatins in the pathway fr calling the Nenatal SHO. Use the SBAR (Situatin- Backgrund-Assessment-Recmmendatin) framewrk t ensure clear cmmunicatin e.g. Infrm Nenatal SHO that: (S) Baby X is X hurs/days ld, has lw bld sugar (level, hw checked), temperature is X C (B) Any risk factrs, (A) Is being managed n pathway and received (X dses f gel) (X bld sugar checks) AND SHO - INFORM SHO - REVIEW SHO - URGENT (R) attendance nt expected (R) attendance required sn but nt urgently (R) attendance required urgently Dextrse Gel Dextrse gel is the immediate first-line treatment fr any lw bld sugar. 0.5mls per kg f 40% dextrse gel shuld be given t the infant (200mg/kg glucse). 0.5mls is apprximately equivalent t the same amunt f 40% dextrse gel that can be generusly applied t an adult fingertip. Therefre the dse is ne full fingertip per kg fr example a 3kg baby wuld require 3 full fingertips wrth f 40% dextrse gel. A 3.5kg baby wuld receive 4 full fingertips etc. The gel is applied tpically t the buccal mucsa. INFANT AT RISK PATHWAY fr thse infants wh have ne (r mre) risk factrs Feed within 30 minutes f birth If first feed is taken within 1 hur f birth, check first BSL prir t the secnd feed (~3 hurs) If first feed mre than 1 hur after birth (pathway failure), check BSL at 2 hurs f age Feeds shuld be ffered 3 hurly The first (pre-feed) BSL shuld be checked n the prtable bld glucse meter The baby s temperature shuld be checked at the time f the BSL If first BSL is 2.6 mml/l then recheck in 9-10 hurs (prir t the 4 th feed). Observe infant n the pstnatal ward fr 24hurs (general bs, mnitr feeding). If there are any further cncerns (such as pr feeding r clinical signs f hypglycaemia), recheck BSL immediately and start a NEW hypglycaemia care plan. If the first pre-feed BSL is <2.6 mml/l, the CBGS shuld be checked (the NICU bld gas machine has a glucse-nly prfile fr this purpse) If the first pre-feed BSL r CBGS is less than 2.6mml/L then give dextrse gel immediately THEN If CBGS between 1.5 and 1.8mml/L AND n symptms/signs SHO - REVIEW Ensure feeding plan being fllwed N frmula tp ups If CBGS between 1.5 and 1.8mml/L AND symptms/signs present SHO ATTEND If CBGS 1.5mml/L then fr immediate SHO/Registrar attendance ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
6 The infant shuld be fed (breast r frmula accrding t maternal preference.) Every step shuld be taken t aid and supprt mthers wh wish t breast feed t help with establishment f breast feeding. Ensure the infant is warm and dry BSL shuld be repeated prir t the next feed (3 hurly). There is n need t take pst-feed BSL Prvided that the bld sugars are stable r imprving and that the infant remains well, treatments with dextrse gel can be used up t three times whilst ensuring warmth and 3 hurly feeding After 3 runds f dextrse gel, if the bld sugar is still lw then ffer tp-up milk supplements (EBM if available, frmula if nt) at 10mls/kg per feed (this equates t apprximately 60mls/kg/day) If this is the baby s first lw glucse reading (i.e. it was nrmal after the first feed but n retesting prir t the furth feed is nw lw) use dextrse gel In line with the UK Baby Friendly Initiative we aim t prmte and supprt breast feeding mthers, whilst ensuring the safety f all infants at risk f hypglycaemia. Mderate hypglycaemia (i.e. BSL mml/L) in an therwise well infant is nt a cntraindicatin t breast feeding, and establishment f breast feeding shuld be supprted at all stages f the care pathway, even when supplemental frmula is required. Expressed breast milk shuld be used first as a supplement (if available), and parents shuld be infrmed as t why infant frmula is being used if this becmes necessary. These guidelines are intended fr the management f therwise well babies n the Pstnatal Ward and Delivery Suite. They are nt intended t replace clinical judgement, and if there are cncerns at any pint the Nenatal SHO r Registrar shuld be cntacted, althugh they are expected t fllw the guideline under nrmal circumstances. Supplements (EBM r frmula) may smetimes be required at day ahead vlumes: 90mls/kg/day n first day, 120mls/kg/day n secnd day, 150mls/kg/day n third day nwards. If a baby is vmiting cnsider ther causes (structural bstructin, sepsis) r cnsider a change t mre frequent smaller vlume feeds. CLINICAL CONCERN PATHWAY Nrmally grwn term infants may be started n the Hypglycaemia Care Plan if there is clinical cncern: if the baby becmes systemically unwell r there are signs f hypglycaemia such as pr tne, excessive sleepiness (>8hurs between feeds), irritability, apnea, jitteriness r seizure activity. In these cases the baby shuld have a first bld sugar level as per the abve pathway. Once the baby has had tw cnsecutive bld sugar levels at 2.6mml/L r mre, mnitring can be stpped. With these infants there is n need t cmplete a further 24 hurs bservatin as per the high risk infants. ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
7 Persistent Hypglycaemia If, despite the abve measures infants remain persistently hypglycaemic r are prfundly hypglycaemic at any stage, further measures will need t be taken. If BSL are mml/l and infants remain systematically well, the cmmencement f day ahead vlumes f EBM/frmula supplements (see abve) and/r feeding mre frequently may be adequate as the next step after dextrse gel (three runds can be used see pathway). Where pssible, it is preferable t use enteral feeding/supplementatin t IV dextrse. If an infant requires tw hurly feeding, a nasgastric tube can be passed and the baby admitted t SCU s that mthers and babies can be kept tgether where pssible. Management f persistent hypglycaemia requiring IV dextrse Any infant wh has persistent symptms, is nt tlerating enteral feeds, r is unable t maintain nrmglycaemia with apprpriate enteral feeds alne shuld be cmmenced n an intravenus infusin f 10% dextrse. This will invlve admissin. Bld tests required will depend n the clinical scenari Infants receiving IV dextrse shuld als receive enteral feeds IF there are n cntraindicatins Nrmal nenatal hepatic glucse prductin rate is 4-6 mg/kg/min start IV 10% dextrse at this rate Fr BSL mml/l despite attempts at enteral management, starting 10% dextrse at 90mls/kg/day will give 6.25mg/kg/min. A blus is nt nrmally required unless the baby is symptmatic, as bluses can prvke rebund hyperinsulinism. Fr BSL <1.5 mml/l (n CBGS) despite treatment (dextrse gel/feed) and/r with symptms (e.g. fitting), give IV blus f 3mls/kg f 10% dextrse AND increase the glucse lad being given (either increasing rate r cncentratin f IV dextrse). D nt give an IV blus withut als using glucse infusin. The aim is t rapidly increase BSL t >2.0 mml/l. Glucse lad shuld be increased in steps f 2mg/kg/min. Use the glucse infusin calculatr Check BSL 30 minutes after initiatin f treatment and then at 2 hurs. Frequency f testing can be reduced if there has been an adequate respnse. If BSL is still lw, the glucse lad needs t be increased. This can be dne by increasing either vlume f 10% dextrse given r increasing the cncentratin f the dextrse. It is imprtant nt t increase the vlume f fluid given beynd 120mls/kg/day n the first day f pstnatal life as there is a risk f hypnatraemia. T increase the cncentratin f dextrse use the 5 and 50 regime and nline calculatr If the cncentratin f dextrse required >12.5% this must be given thrugh a central line (UVC/lng line) At all stages dcument the amunt f glucse being given in mg/kg/min Further bluses can be given if there are further episdes f severe r symptmatic hypglycaemia but this shuld nt be dne in islatin: glucse lad shuld als be increased AND cause fr the drp shuld be searched fr (tissued IV line, pssible metablic cnditin etc.) The attending/n call cnsultant shuld be infrmed f all infants with persistently severely hypglycaemia and f infants requiring >12mg/kg/minute IV glucse Once BSL >2.6 mml/l fr 24 hurs, reduce IV fluids and increase enteral fluids as apprpriate every 6 hurs, checking bld sugars 4 hurly. On full enteral feeds check BSL every 6 hurs fr 24 hurs, then 12 hurly fr 24 hurs, then cease testing if BSL cnsistently >2.6mml/L ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
8 5 & 50 glucse regime By running 5% and 50% dextrse as simultaneus infusins, glucse lad (mg/kg/min) and flw rate (mls/hr) can be independently adjusted. If final glucse cncentratin is >12.5%, run infusin thrugh a central line (UVC r lng line). Electrlytes can be added t these infusins the ttal desired amunt (in mml/kg/day) added t bth infusins, calculated fr bth as if run at the full ttal daily vlume (mls/kg/day). Fr example, 4mml/kg/day NaCl desired at 120mls/kg/day wuld need 16.6mml NaCl t be added t ne 500ml bag f fluid. Therefre add 16.6mml NaCl t BOTH the 5% dextrse and 50% dextrse bag (as if each wuld run at 120mls/kg/day). 120mls/kg/day will be delivered by a cmbinatin f the 5% and 50% dextrse depending n the glucse lad required but regardless f the final glucse cncentratin 4mml/kg/day f NaCl will be delivered). Glucagn fr severe hypglycaemia Glucagn (100mcg/kg IM) may be required in the fllwing situatins: Unable t gain IV access in newly admitted infant with symptmatic hypglycaemia Lss f IV access in presence f significant/symptmatic hypglycaemia Persistence f hypglycaemia despite increasing glucse infusin rate Presence f seizures and hypglycaemia Rarely an IV blus r infusin f glucagn might be needed. Rates f mcg/kg/hr can be given IV r subcutaneusly Further Management f Persistent Hypglycaemia If infant remains hypglycaemic despite glucse lad f 12mg/kg/min take blds (preferably when baby is hypglycaemic but d NOT delay treatment) fr: FIRST LINE Labratry Glucse FBC, LFTs, TFTs Bld gas with lactate Insulin level [send t RSCH speak t bichemist, emphasise urgent sample, same day result needed] Crtisl Grwth hrmne Urine diptest fr ketnes SECOND LINE Ammnia (speak t bichemist, needs t g t lab immediately n ice) Lactate Fatty acids Ketne bdies Carnitine and acetylcarnitine (n bld spt frm) Urine rganic acids ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
9 Further testing such as lumbar puncture fr CSF glucse depends n the clinical scenari / histry. High insulin levels with hypglycaemia and n urinary ketnes indicates hyperinsulinism. In hyperinsulinism it is nt unusual t have a glucse requirement f 15-20mg/kg/min Sme babies may benefit frm Infatrini frmula fr extra glucse intake. This shuld be discussed with the attending Cnsultant and (if pssible) the Dietician first. The Nutritinal Calculatr can be used t wrk ut glucse delivery rates. Treatment with diazxide / chlrthiazide shuld be cnsidered (by the attending Cnsultant). Ttal fluids shuld be reduced t 120mls/kg/day as diazxide may cause fluid retentin. Dr Bahl will advise n management and Dr Khalid Hussein at GOSH may be cntacted if advice/transfer if required fr refractry cases. Fllw up All significantly symptmatic babies and thse wh have required mre than 12mg/kg/min f glucse infusin shuld be fllwed up as utpatients. Please discuss with the attending Cnsultant. ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
10 References Alkalay AL, Sarnat HB, Flres-Sarnat L et al.ppulatin meta-- analysis f lw plasma glucse threshlds in full- - term nrmal newbrns. Am J Perinatl 2006; 23: Aynsley-- Green A etal. Practical management f hyperinsulinism in infancy. Arch Dis Child Fetal Nenatal Ed 2000; 82: F98-F107 Burns et al. Patterns f cerebral injury and neurdevelpmental utcmes after symptmatic nenatal hypglycaemia. Pediatrics 2008; 122(1): Chantry CJ, Hward CR. Clinical Prtcls fr Management f Breastfeeding. Pediatr Clin N Am 2013;60:1, Crnblath M et al. Cntrversies regarding definitin f nenatal hypglycaemia:suggested peratinal threshlds. Paediatrics 2000 May; 105 (5): Crnblath M, Ichrd R. Hypglycemia in the nenate. Semin Perinatl 2000;24(2): Diwaker et al. Plasma glucse levels in term infants wh are apprpriate size fr gestatin and exclusively breast fed. Arch Dis Child Fetal Nenatal Ed 2002; 87: F46-48 Harris DL et al. Incidence f nenatal hypglycaemia in babies defined as at risk. J Pediatr 2012; 161: Harris DL et al. Dextrse gel fr nenatal hypglycaemia (the Sugar Babies Study): a randmised, duble-blind, placebcntrlled trial. The Lancet 2013; 302: Hawdn JM. Investigatin, preventin and management f nenatal hypglycaemia (impaired pstnatal metablic adaptatin). Paediatrics and Child Health 2012; 22:4, Hawdn JM. Definitin f nenatal hypglycaemia: time fr a rethink? Arch Dis Child Fetal Nenatal Ed 2013;98(5):F382-3 Hlmes AV. Establishing Successful Breastfeeding in the Newbrn Perid. Pediatr Clin N Am 2013; 60:1, Hussain K. Investigatins fr nenatal hypglycaemia. Clin Bichem 2011;44(7): Lucas A et al. Adverse neurdevelpmental utcme f mderate nenatal hypglycaemia. Arch Dis Child;63: Natinal Institute fr Health and Care Excellence. Diabetes in pregnancy: management f diabetes and its cmplicatins frm pre-cnceptin t the pstnatal perid. CG63. Lndn: Natinal Institute fr Health and Care Excellence; Stewart C, Sage E, Reynlds P. Supprting Baby Friendly : a quality imprvement initiative fr the management f transitinal nenatal hypglycaemia. Arch Dis Child Fetal Nenatal Ed 2015;0:F1 F4 Sundercmbe SL et al. Audit f a clinical guideline fr nenatal hypglycaemia screening. J Paediatr Child Health 2013 Sweet CB, Graysn S, Plak M. Management Strategies fr Nenatal Hypglycemia. J Pediatr Pharmacl Ther 2013;18(3): Guidance n the develpment f plicies and guidelines fr the preventin and management f Hypglycaemia f the Newbrn UNICEF UK Baby Friendly Initiative. Vannucci RC. Hypglycaemic brain injury. Semin Nenatal Apr; 6 (2): Guidelines prepared by Dr. Matthews, Dr. Sage, Dr. Reynlds March 2014 Updated by Dr. Farah, Dr. Reynlds January 2016 ASPH Nenatal Hypglycaemia Guideline 2016 v1.3
Swindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationNeonatal Jaundice Guideline
Nenatal Jaundice Guideline Guideline Number: 663 Supersedes: Classificatin Clinical Versin N: Date f EqIA: Apprved by: Date Apprved: Date made active: Review Date: 1 Obstetric Written Dcumentatin Review
More informationPrevention and Management of Hypoglycaemia
Prevention and Management of Hypoglycaemia Use for ALL babies on the Labour Ward, Postnatal Ward & Transitional Care. This guideline is based on the BAPM Hypoglycaemia Guideline 2017. This guideline should
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment
More informationHyperglycaemia: Management of Preterm Infants in Neonatal Intensive Care
1. Purpse Hyperglycaemia in preterm infants is likely due t a number f factrs (impaired insulin secretin, insulin resistance and immaturity f glucse hmestasis regulatin) 1,2. Hyperglycaemia has been assciated
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationPrinted copies of this document may not be up to date, obtain the most recent version from Author Position
Printed cpies f this dcument may nt be up t date, btain the mst recent versin frm www.cats.nhs.uk Children s Acute Transprt Service Clinical Guidelines Diabetic Ketacidsis Dcument Cntrl Infrmatin Authr
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More informationAppendix C Guidelines for treating status epilepticus in adults and children
Appendix C Guidelines fr treating status epilepticus in adults and children 1.1 Treating cnvulsive status epilepticus in adults General measures 1st stage (0 10 minutes) Secure airway and resuscitate Administer
More informationGuidelines for the Admission of Children and Young People with an Eating Disorder
Guidelines fr the Admissin f Children and Yung Peple with an Eating Disrder This dcument is designed t be used by clinicians lcated in hspitals f wards withut specialist eating disrder facilities, t guide
More informationGuidelines for the Prevention and Management of Hypoglycaemia
ASHFORD & ST PETER S HOSPITALS NHS TRUST CHILDREN S SERVICES Guidelines for the Prevention and Management of Hypoglycaemia 1. The Care Plan for Prevention of Hypoglycaemia on Labour Ward and the Postnatal
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationUniversity College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service
University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationCode of employment practice on infant feeding
Cde f emplyment practice n infant feeding An Emplyer s guide t: Sectin 69Y f the Emplyment Relatins Act 2000 Frewrd As Minister f Labur, I am pleased t publish the Cde f Emplyment Practice n Infant Feeding.
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationYear 1 MBChB Clinical Skills Session Blood Glucose Monitoring
Year 1 MBChB Clinical Skills Sessin Bld Glucse Mnitring Reviewed & ratified by: Dr V Taylr-Jnes, Cnsultant Anaesthetist Ms C Tierney, HARC Elements discussed with Ms Lesley Lamen, Diabetic Nurse Specialist
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationH1N1 Influenza 09 Guidance for Residential Aged Care
H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationINTRAVENOUS FLUID THERAPY CLINICAL CARE RECOMMENDATIONS
INTRAVENOUS FLUID THERAPY CLINICAL CARE RECOMMENDATIONS Clinical Assessment Vital signs n admissin Evaluate hydratin status clinically Mnitring Vital signs per nursing prtcl Dcument intake and utput Onging
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationIschemic heart disease (angina/chest pain)
Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationEating Disorders. what do GPs need to know? John O Brien May 2016
Eating Disrders what d GPs need t knw? Jhn O Brien May 2016 Overview Eating, weight and eating disrders Case scenari Hw t spt them When t refer Management pre and pst referral Eating and weight Adlescence
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationGetting Started. Learning Guide. with Continuous Glucose Monitoring for the MiniMed 530G with Enlite. CGM Foundations
Getting Started with Cntinuus Glucse Mnitring fr the MiniMed 530G with Enlite Learning Guide CGM Fundatins Cntinuus Glucse Mnitring Learning Guide MiniMed 530G with Enlite - Cntinuus Glucse Mnitring Settings
More informationBritish Sign Language (BSL) Plan October 2018 Scottish Charity Regulator
British Sign Language (BSL) Plan 2018-2024 Octber 2018 Scttish Charity Regulatr Cntents Sectin 1: Intrductin and cntext 1.1 Intrductin 1.2 Our wrk and what we d Sectin 2: Our BSL Plan 2.1 Scttish Public
More informationCnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level
More informationPolicy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning
Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationStructured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information
Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationSECTION O. MEDICATIONS
SECTION O. MEDICATIONS 1. NUMBER OF MEDICA TIONS (Recrd the number f different medicatins used in the last 7 days; enter "0" if nne used) O1. Number f Medicatins (7-day lk back) Intent: Prcess: Cding:
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationUrinary tract infection (lower) - women - Management
Urinary tract infectin (lwer) - wmen - Management Scenari: Cystitis in wmen wh are nt pregnant Hw shuld I manage a wman with suspected cystitis? Cnvey a psitive apprach and reassure the wman that cystitis
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationRecord of Revisions to Patient Tracking Spreadsheet Template
Recrd f Revisins t Patient Tracking Spreadsheet Template Belw is a recrd f revisins made by the AIMS Center t the Patient Tracking Spreadsheet Template. The purpse f this dcument is t infrm spreadsheet
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationSchool Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:
Schl Medicatin Authrizatin Frm Student's Name Address Birth Date Hme Phne Schl Grade Teacher Emergency Phne N: T be cmpleted by the student's physician: Name f Medicatin: Dsage Frequency Time t be given
More informationRecommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012
Recmmendatins fr Risk Management at Swine Exhibitins and fr Shw Pigs August 2012 Backgrund: The Natinal Prk Bard facilitated in develping this dcument. These recmmendatins were develped by a wrking grup
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationQUALITY AND SAFETY MEASURES UPDATE January 2016
CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:
More informationLyme Disease Surveillance in North Carolina
Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014
More informationFrequently asked questions: Influenza A (H1N1)v
July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,
More informationITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.
Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet
More informationType 1 Diabetes Mellitus
Type 1 Diabetes Mellitus Imprtant Pints in Histry Plyuria, thirst and plydipsia Plyphagia Weight lss Vmiting Abdminal pains Onset f enuresis in a previusly tilet trained child. New presentatin r acute
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationChapter 6: Impact Indicators
Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More informationProstatitis - chronic - Management
Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationManaging the Symptoms of Stroke
Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening
More informationResponse to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines
Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at
More informationContinuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator
Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results
More informationInfection Control Guidelines for Cabin Crew Members on Commercial Aircraft
Infectin Cntrl Guidelines fr Cabin Crew Members n Cmmercial Aircraft PURPOSE These guidelines prvide cabin crew members (flight attendants) with practical measures t prtect themselves, passengers, and
More informationPaediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead
Paediatric Sepsis Frm Sinéad Hrgan SSWHG Sepsis Lead www.hse.ie/sepsis Definitin A life-threatening rgan dysfunctin due t a dysregulated hst respnse t infectin N cnfirmatry test Bld cultures are psitive
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationSURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation
SURGICAL NOTE Surgical Recmmendatins t Optimize Femral/Iliac Artery Cannulatin Due t its size, lcatin, and ease f access, the femral artery is frequently used fr bld pressure catheter placement. Less frequently,
More informationGSB of EDA Meeting Minutes
Hell Everyne! We held a General Service Bard meeting n 04/10/2013. Attendees: Alita, British Clumbia, CAN Annette H, Phenix, AZ Fran, IL Rachel F, Tempe, AZ Rger, MA Vanessa S, Lngwd, FL Ntes: Rger asked
More informationWaterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION
Waterl Wellingtn Rehabilitative Care System Integrated Care Pathway fr STROKE Stream f Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Care Setting Activity Patients wh present t a cmmunity
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationTopic 12: Endocrine System. Function: Group of glands that produces regulatory chemicals ( )
Tpic 12: Endcrine System Functin: Grup f glands that prduces regulatry chemicals ( ) Hrmnes: Chemical messengers released directly int the bldstream that regulate: *May have wide-spread effects r nly affect
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationMEDICATION GUIDE. (canagliflozin) Tablets
MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can
More informationINFERTILITY DIAGNOSIS
INFERTILITY Infertility is the inability t cnceive after 12 mnths f unprtected intercurse. There are multiple causes f infertility and a systematic way t evaluate the cnditin. Let s lk at sme f the causes.
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationTELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT
TELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT Intrductin This is the Explanatry Statement fr the revised Cmmunicatins Alliance Telecmmunicatins Cnsumer Prtectins (TCP) Industry
More informationPediatric and adolescent preventive care and HEDIS *
Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness
More informationIron and Iron Deficiency
Irn and Irn Deficiency Irn and why we need it Irn is a mineral needed by ur bdies. Irn is a part f all cells and des many things in ur bdies. Fr example, irn (as part f the prtein hemglbin) carries xygen
More informationCOPING WITH STRESS IN PARENTS OF CHILDREN AFTER RENAL TRANSPLANTATION
COPING WITH STRESS IN PARENTS OF CHILDREN AFTER RENAL TRANSPLANTATION Mgr. Lucia Lukackva Mgr. Zuzana Kcabva University Hspital Mtl Sectin fr Pediatric Nephrlgy Prague, Czech Republic Research gals pint
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationAlcohol & Substance Misuse Policy. St Mary s CE Academy Trading Company. Date: Spring 2017 Date of Next Review: Summer 2018
St Mary s CE Academy Trading Cmpany Alchl & Substance Misuse Plicy Date: Spring 2017 Date f Next Review: Summer 2018 Signed by: Family Supprt Crdinatr Signed by: Grup Manager Alchl and Substance Misuse
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationICD-10-CM Coding Basics Chapter Specifics
ICD-10-CM Cding Basics Chapter Specifics Chapter 15 Pregnancy, Childbirth and the Puerperium Vilma Smith, LVN, CPC, CCS Debra Bales, LVN, CPC Jnay Rischer, CPC 1 Rev. May 2015 ICD-10-CM Cnventins General
More information